Tesamorelin + Ipamorelin

Supplied as a single lyophilized vial for in-vitro and laboratory research only, this research-grade preparation pairs 10mg of Tesamorelin with 3mg of Ipamorelin. Lyophilized means the peptides are freeze-dried into a stable powder for laboratory reconstitution.

Tesamorelin belongs to the GHRH-analog class. GHRH stands for growth-hormone-releasing hormone, and an analog is a molecule built to resemble a natural sequence. Ipamorelin belongs to the growth-hormone secretagogue class, compounds studied for their action on secretion-related receptors.

This particular ratio places a higher proportion of the secretagogue component alongside the GHRH analog. Researchers select defined ratios like this one to examine how the balance between two receptor pathways behaves in a single experimental system.

This product is furnished strictly for in-vitro laboratory research. It is not for human consumption. It is not approved by the FDA or EMA to prevent, treat, or cure any condition. Introduction into humans or animals is prohibited by law.

The research interest in this preparation lies in the interaction of two separate receptor systems studied side by side. Each component engages a different receptor, so the blend supports comparative pathway work within one preparation.

Tesamorelin is examined for binding at the GHRH receptor, a class B G protein-coupled receptor. Ipamorelin is examined for activity at the ghrelin receptor. Because these receptors are distinct, laboratory models can observe each route and their combined signaling profile.

The defined 10mg to 3mg ratio is itself a variable of interest. Comparative studies may set this preparation against other ratios to analyze how component proportions influence measured receptor responses in vitro.

Typical research areas include receptor-binding assays, signal transduction, and second-messenger analysis. Second messengers are molecules that relay signals inside a cell after a receptor is activated. All findings come from controlled laboratory environments. This product is not for use in humans or animals.

The preparation arrives as a lyophilized powder containing both peptides. Only qualified personnel using sterile laboratory technique should handle it.

Keep the sealed vial at 2–8°C before reconstitution, away from moisture and light, and freeze it for extended storage. Stable, consistent conditions protect the molecular integrity of both components.

To reconstitute, dissolve the powder in a sterile laboratory solution such as bacteriostatic or sterile water; the correct solvent, volume, and concentration should be taken from the lot-specific documentation and Certificate of Analysis. Introduce the solvent slowly against the inner wall of the vial and avoid shaking, which can stress the peptides.

Once reconstituted, hold the solution at 2–8°C and use it within a validated timeframe. Record compound name, concentration, solvent, lot number, and preparation date on every sample, and discard unused material following institutional laboratory waste protocols.

This product is supplied in a research vial format only and is labeled For Research Use Only.

Purity is verified for every batch by LC-MS analysis to confirm research-grade quality. LC-MS, or high-performance liquid chromatography, is a standard method for measuring how pure a compound is.

A Certificate of Analysis is provided with each order, recording purity results and confirming the identity of both peptides. Specifications should always be read from this lot-specific documentation rather than judged by appearance.

Molecular weight and compound identity are checked for each component so the vial can be confirmed to contain the expected peptides at the stated quantities. Molecular weight is the measured mass of a peptide.

Consistent results from batch to batch support reliable research protocols, and internal quality standards hold each batch to strict specifications. This documentation supports accurate research records and institutional compliance.

• CAS: Tesamorelin: 218949-48-5 / Ipamorelin: 170851-70-4
• Chemical Formula: Tesamorelin: C₂₂₁H₃₆₆N₇₂O₆₇S Ipamorelin: C₃₈H₄₉N₉O₅
• Molecular Weight: Tesamorelin: 5136 g/mol Ipamorelin: 711.9 g/mol
• Peptide Sequence: Tesamorelin: Trans-3-hexenoyl-Tyr Ala Asp Ala Ile Phe Thr Asn Ser Tyr Arg Lys Val Leu Gly Gln Leu Ser Ala Arg Lys Leu Leu Gln Asp Ile Met Ser Arg Gln Gln Gly Glu Ser Asn Gln Glu Arg Gly Ala Arg Ala Arg Leu NH2 Ipamorelin: Aib-His-D-2Nal-D-Phe-Lys-NH₂
• Synonyms: TH9507
• Shelf life: 24 months from the manufacturing date.

Two synthetic peptides are co-formulated in this single vial. Synthetic production, meaning laboratory synthesis rather than natural extraction, supports batch-to-batch consistency for research.

Tesamorelin (10mg)

Tesamorelin is a stabilized synthetic analog of growth-hormone-releasing hormone. It is studied for its interaction with the GHRH receptor and forms the larger component of this preparation by mass.

Ipamorelin (3mg)

Ipamorelin is a synthetic pentapeptide, a five-amino-acid chain studied as a selective ghrelin-receptor agonist. Selective means it is examined for acting on a specific receptor with limited activity elsewhere.

These structural and chemical characteristics are studied under standardized protocols. This product is supplied strictly for in-vitro research. It is not for human consumption.